1. A Comprehensive View on the Quercetin Impact on Colorectal Cancer
   Andreea-Adriana Neamtu et al, 2022, Molecules CrossRef
2. Special Agents Hunting Down Women Silent Killer: The Emerging Role of the p38αKinase
   Valentina Grossi et al, 2012, Journal of Oncology CrossRef
3. Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway
   Mathieu Chocry et al, 2017, Oncotarget CrossRef
4. p38γ Activation and BGP (Biliary Glycoprotein) Induction in Primates at Risk for Inflammatory Bowel Disease and Colorectal Cancer—A Comparative Study with Humans
   Harvinder Talwar et al, 2020, Vaccines CrossRef
5. p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance
   Valentina Grossi, 2014, World Journal of Gastroenterology CrossRef
6. Overcoming P-Glycoprotein-Mediated Doxorubicin Resistance
   Suree Jianmongkol, 2021, Advances in Precision Medicine Oncology CrossRef
7. From DNA Damage to Cancer Progression: Potential Effects of Cytolethal Distending Toxin
   Yi-Ru Lai et al, 2021, Frontiers in Immunology CrossRef
8. The Therapeutic Potential of Targeting Autophagy in the Treatment of Cancer
   Negin Chaeichi-Tehrani et al, 2021, Current Cancer Drug Targets CrossRef
9. Hyaluronic Acid Layered Chimeric Nanoparticles: Targeting MAPK-PI3K Signaling Hub in Colon Cancer Cells
   Sandeep Palvai et al, 2017, ACS Omega CrossRef
10. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer
    Ashraf N. Abdalla et al, 2021, Molecules CrossRef
11. GSTs, MRP and Apoptototic Markers in DLD-1 Human Colon Cancer Cell Line Before and After 5-FU Treatment
    Fatıma Nurdan GÜRBÜZ et al, 2022, International Journal of Nature and Life Sciences CrossRef
12. IFI6 Downregulation Reverses Oxaliplatin Resistance of Colorectal Cancer Cells by Activating the ROS-Induced p38MAPK Signaling Pathway
    Chen Huang et al, 2023, Biological and Pharmaceutical Bulletin CrossRef
13. Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers
    Giulia Bon et al, 2017, Oncotarget CrossRef
14. Novel Potent EGFR-JAK3 Dual-Target Inhibitor that Overcomes KRAS Mutation Resistance in Colorectal Cancer
    Lixue Chen et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
15. The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic Treatments
    Angelina Pranteda et al, 2020, International Journal of Molecular Sciences CrossRef
16. p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story
    Jesús García-Cano et al, 2016, Frontiers in Cell and Developmental Biology CrossRef